2018
DOI: 10.18632/oncotarget.23986
|View full text |Cite
|
Sign up to set email alerts
|

RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases

Abstract: PurposeMedullary Thyroid Cancer (MTC) whose pathogenesis is strictly related to RET proto-oncogene alterations, has been shown to have a heterogenic RET mutation profile in subpopulations of MTC. The aim of our study was to investigate the RET somatic mutation profile in primary MTC and in the corresponding metastatic tissues in a series of advanced metastatic cases.ResultsThis study demonstrated that in about 20% of cases a different RET mutation profile can be found when comparing primary tumor and its corre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
16
0
5

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
3

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(23 citation statements)
references
References 43 publications
(49 reference statements)
2
16
0
5
Order By: Relevance
“…As reported in a large series [ 86 ], RET mutations are almost always mutually exclusive, and only in few cases, multiple RET somatic mutations are present, suggesting that MTC is a rather stable tumor. This evidence was also reported in additional studies [ 87 , 88 ] that demonstrated that only in about 20% of cases a different RET mutation profile could be found when comparing primary tumor and its corresponding metastases. NGS studies have also allowed the definition of the frequency of the mutated allele (AF) and have demonstrated that larger tumors not only are characterized by a higher prevalence of RET somatic mutations [ 89 ] but also have a higher AF corresponding to a higher number of mutated cells.…”
Section: Oncogenic Alterations In Mtcsupporting
confidence: 80%
“…As reported in a large series [ 86 ], RET mutations are almost always mutually exclusive, and only in few cases, multiple RET somatic mutations are present, suggesting that MTC is a rather stable tumor. This evidence was also reported in additional studies [ 87 , 88 ] that demonstrated that only in about 20% of cases a different RET mutation profile could be found when comparing primary tumor and its corresponding metastases. NGS studies have also allowed the definition of the frequency of the mutated allele (AF) and have demonstrated that larger tumors not only are characterized by a higher prevalence of RET somatic mutations [ 89 ] but also have a higher AF corresponding to a higher number of mutated cells.…”
Section: Oncogenic Alterations In Mtcsupporting
confidence: 80%
“…Also, mutations in codons 618, 603, 634, 768, 804, and 883 and partial deletion of the RET gene have been described in a few tumors (Dvorakova et al 2008, Elisei et al 2008, Romei et al 2016. However, the mutations are not uniform throughout the tumor, suggesting that sporadic MTC might have a polyclonal origin or that these mutations are secondary events of MTC tumorigenesis (Eng et al 1996b, Romei et al 2018.…”
Section: Sporadic Mtcmentioning
confidence: 99%
“…In the present study, the majority of samples (86.7%) are diploid for the RET gene suggesting substantial genomic stability of this thyroid cancer histotype. The genomic stability of MTC was already appreciated in previous studies of our group showing that only 8% of sporadic MTC showed more than one somatic mutation and that only 20% of cases have different mutational profiles when comparing the primary with the corresponding metastatic tissues [ 21 , 22 ]. Supporting our data, Fisk et al also found a few genomic alterations when analysing sporadic MTC by array-CGH [ 17 ].…”
Section: Discussionmentioning
confidence: 94%